Griseofulvin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
42794-012 -
Package NDC
42794-012-08 -
Application number
ANDA202482 -
SPL ID
e8a91e6c-8bed-66f5-e053-2a95a90aa489 -
SPL set ID
5bafb97f-621b-4b96-a787-68e0bb5c8637 -
UNII
32HRV3E3D5 -
RxCUI
310600
What the source publishes
- Labeler
- Sigmapharm Laboratories, LLC
- Active ingredients
- Griseofulvin
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Griseofulvin",
"splId": "e8a91e6c-8bed-66f5-e053-2a95a90aa489",
"labels": [
{
"setId": "5bafb97f-621b-4b96-a787-68e0bb5c8637",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5bafb97f-621b-4b96-a787-68e0bb5c8637",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5bafb97f-621b-4b96-a787-68e0bb5c8637"
}
],
"routes": [
"ORAL"
],
"labeler": "Sigmapharm Laboratories, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (42794-012-08)",
"package_ndc": "42794-012-08",
"identifierStatus": "well-formed",
"marketing_start_date": "20160701"
}
],
"productId": "42794-012_e8a91e6c-8bed-66f5-e053-2a95a90aa489",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "42794-012",
"deaSchedule": null,
"genericName": "Griseofulvin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "GRISEOFULVIN",
"strength": "500 mg/1"
}
],
"applicationNumber": "ANDA202482",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20121206",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008732",
"N0000175085",
"N0000175848"
],
"upc": [
"0342794012082"
],
"unii": [
"32HRV3E3D5"
],
"rxcui": [
"310600"
],
"spl_set_id": [
"5bafb97f-621b-4b96-a787-68e0bb5c8637"
],
"pharm_class_pe": [
"Decreased Mitosis [PE]",
"Microtubule Inhibition [PE]"
],
"pharm_class_epc": [
"Tubulin Inhibiting Agent [EPC]"
],
"manufacturer_name": [
"Sigmapharm Laboratories, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:42794-012_e8a91e6c-8bed-66f5-e053-2a95a90aa489"